The most technologically versatile device for cryoneurolysis.
try for free
financing
* Thanks to our cooperation with SIEMENS FINANCE, you have the opportunity to get a medical loan in 15 minutes without leaving your office. Making your plans come true has never been easier!
Cryoanalgesia – freedom from chronic pain.
Reversible and repeatable method. It turns off pain without permanently damaging tissues.
Advantages of cryoanalgesia
It affects the reduction of doses or withdrawal of strong painkillers.
Immediate pain reduction - already during the procedure.
Pain reduction from 6 months to 2 years – depending on the indications and the patient.
It can be repeated as many times as the pain returns.
Excellent visibility of the procedure in the ultrasound - probe, ice zone.
Used in a combination of ultrasound and X-Ray.
Safe: no formation of scar tissue, no risk of proliferation and obliteration of blood vessels, does not destroy muscle tissue, fascia, adipose tissue.
No neuroma formation – no risk of secondary pain.
Excellent for neuromas caused by other procedures: neurotomy, thermolesion, amputation.
Clinical use
Chest wall pain, chest pain after thoracotomy, mastectomy.
Facial pain, such as trigeminal neuralgia, other neuralgias.
Occipital neuralgia, suprascapular neuralgia, ilioinguinal neuralgia and other types of neuralgia.
Degeneration of the intervertebral joints (facet syndrome).
Pain and spasticity of the upper and lower limbs, denervation of the knee, shoulder, hip.
The thinnest cryoanalgesia cryoprobes available in the global pain management market. We offer both disposable and reusable, easy-to-sterilize (steam) cryoprobes. The special and patented design allows precise freezing and quick defrosting. The shape of the probe and the different designs of the freezing parts make it possible to freeze nerves regardless of their location and diameter.
CRYO-S Painless
Easy mode switching
Probe mode selection, cleaning and freezing can be performed automatically via a foot switch or a convenient touchscreen, allowing the treatment site to be kept in sterile conditions.
RFiD
RFiD – electronic communication between the probe and the device allows for the recognition of optimal operating parameters and automatic configuration to the characteristics of the cryoprobe. The gas pressure and flow are set automatically, and manual adjustment is not necessary.
Automated Testing System
It is equipped with an automatic probe testing system and two freezing modes (continuous and sequential). The probe testing system includes automatic cleaning and short freezing test.
Voice communication
Built-in voice communication makes the work easier. A system informing about key data during the procedure.
Safe freezing
Built-in diagnostic nerve stimulation helps distinguish between sensory and motor nerves. This prevents the motor nerves from accidentally freezing.
Two working mediums
The working medium for CRYO-S® Painless is carbon dioxide CO2 (-78°C) or nitrous oxide N2O (-89°C), very efficient and easy-to-use gases.
Cryoprobes
Accuracy
Cryoprobes are coated with medical Teflon. Therefore, stimulation is carried out only at the tip of the probe.
Visible under ultrasound
The ice zone and all cryoprobes are visible on ultrasound images – they are hyperechoic.
Diversity
The largest range of cryoprobes allows you to find the best solution.
User-friendly interface
CRYO-S ® Painless is controlled by a microprocessor, and all parameters are displayed and monitored on the LCD screen. Cryoprobe temperature, cylinder pressure, gas flow inside the cryoprobe and the treatment time are displayed during freezing.
CRYO-S® PAINLESS, the most modern cryosurgical device manufactured by METRUM CRYOFLEX, is a new generation device used by many experts in the field since 1992.
Creating the future of medicine together
Our medical technologies and solutions help shape modern healthcare, improving the effectiveness of therapy and the comfort of patients.
Metrum Cryoflex Sp z o.o. Zielna 29 05-082 Blizne Łaszczyńskiego near Warsaw, Poland
Registration: District Court for the Capital City of Warsaw, XIV Commercial Division Share capital: PLN 8,000,000.00
